<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02437721</url>
  </required_header>
  <id_info>
    <org_study_id>2014-05-06-MTHF</org_study_id>
    <nct_id>NCT02437721</nct_id>
  </id_info>
  <brief_title>Suitability of an Infant Formula With L-5-Methyltetrahydrofolate for the Particular Nutritional Use in Infants</brief_title>
  <acronym>MEFOLIN</acronym>
  <official_title>Suitability of an Infant Formula With L-5-Methyltetrahydrofolate for the Particular Nutritional Use in Infants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>DSM Nutritional Products, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>KBC Dr Dragisa Misovic-Dedinje</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>HiPP GmbH &amp; Co. Vertrieb KG</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Institute for Laboratory Diagnostics Konzilijum</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Bevital AS</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sermon CRO</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ludwig-Maximilians - University of Munich</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>DSM Nutritional Products, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is designed to show equivalence of an infant formula containing L-5-
      Methyltetrahydrofolate (MTHF) compared to a standard infant formula containing folic acid in
      respect to weight gain of healthy term infants receiving these infant formulae exclusively
      during the first 4 months of life. Healthy non breast fed infants will be randomized to
      receive either a standard infant formula with folic acid or a corresponding formula with MTHF
      instead of folic acid. Besides weight and length further anthropometric measures will be
      taken monthly from the age of 4 weeks to the age of 16 weeks and at the age 4 and 16 weeks
      blood samples will be taken for the determination of folate status and genotyping. As a
      reference the same measures will be taken in a group of breast fed infants, whose mothers`
      folate status will be determined as well.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>May 2015</start_date>
  <completion_date type="Anticipated">April 2018</completion_date>
  <primary_completion_date type="Actual">August 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>weight gain (gram/day)</measure>
    <time_frame>age of 4 weeks until age of 16 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>body length gain (cm/day)</measure>
    <time_frame>age of 4 weeks until age of 16 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>fronto-occipital head circumference gain (in cm/day)</measure>
    <time_frame>at age of 4 weeks and at the age of 16 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>dietary intake of study formula, non-study formula, additional liquids and solids</measure>
    <time_frame>during the period age 4 weeks to age 16 weeks</time_frame>
    <description>dietary intake will be determined as kcal per day and as kcal per kg body weight per day</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>feeding related behavior questionnaire</measure>
    <time_frame>during the period age 4 weeks to age 16 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>stool characteristics (color and consistency)</measure>
    <time_frame>during the period age 4 weeks to age 16 weeks</time_frame>
    <description>stool characteristics are assessed by the Bristol scale criteria</description>
  </secondary_outcome>
  <other_outcome>
    <measure>plasma levels of 5-MTHF in infants</measure>
    <time_frame>at age of 4 weeks and at the age of 16 weeks</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>plasma levels of folic acid in infants</measure>
    <time_frame>at age of 4 weeks and at the age of 16 weeks</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>plasma levels of 5-Formyl-tetrahydrofolate (fTHF) in infants</measure>
    <time_frame>at age of 4 weeks and at the age of 16 weeks</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>plasma levels of 4-Alfa-hydroxy-5-methyl-THF (hmTHF) in infants</measure>
    <time_frame>at age of 4 weeks and at the age of 16 weeks</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>plasma levels of Para-aminobenzoylglutamate (pABG) in infants</measure>
    <time_frame>at age of 4 weeks and at the age of 16 weeks</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>plasma levels of Acetamidobenzoylglutamate (apABG) in infants</measure>
    <time_frame>at age of 4 weeks and at the age of 16 weeks</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>red cell total folate in infants</measure>
    <time_frame>at age of 4 weeks and at the age of 16 weeks</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>plasma levels of 5-MTHF in breast feeding mothers</measure>
    <time_frame>at the infantile age of 8 weeks</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>breast milk levels of 5-MTHF in breast feeding mothers</measure>
    <time_frame>at the infantile age of 8 weeks</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>plasma levels of folic acid in breast feeding mothers</measure>
    <time_frame>at the infantile age of 8 weeks</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>breast milk levels of folic acid in breast feeding mothers</measure>
    <time_frame>at the infantile age of 8 weeks</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>plasma levels of fTHF in breast feeding mothers</measure>
    <time_frame>at the infantile age of 8 weeks</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>breast milk levels of fTHF in breast feeding mothers</measure>
    <time_frame>at the infantile age of 8 weeks</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>plasma levels of hmTHF in breast feeding mothers</measure>
    <time_frame>at the infantile age of 8 weeks</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>breast milk levels of hmTHF in breast feeding mothers</measure>
    <time_frame>at the infantile age of 8 weeks</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>plasma levels of pABG in breast feeding mothers</measure>
    <time_frame>at the infantile age of 8 weeks</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>breast milk levels of pABG in breast feeding mothers</measure>
    <time_frame>at the infantile age of 8 weeks</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>plasma levels of apABG in breast feeding mothers</measure>
    <time_frame>at the infantile age of 8 weeks</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>breast milk levels of apABG in breast feeding mothers</measure>
    <time_frame>at the infantile age of 8 weeks</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>hemoglobin value of the breast feeding mothers</measure>
    <time_frame>at the infantile age of 8 weeks</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>hematocrit value of the breast feeding mothers</measure>
    <time_frame>at the infantile age of 8 weeks</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>mean corpuscular volume (MCV) of the breast feeding mothers</measure>
    <time_frame>at the infantile age of 8 weeks</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>weight of infants</measure>
    <time_frame>at infantile age 1 year</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>length of infants</measure>
    <time_frame>at infantile age 1 year</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>head circumference of infants</measure>
    <time_frame>at infantile age 1 year</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>hemoglobin value of infants</measure>
    <time_frame>between Day 1 and Day 27 of life, at infantile age of 16 weeks and of 12 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>hematocrit value of infants</measure>
    <time_frame>between Day 1 and Day 27 of life, at infantile age of 16 weeks and of 12 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>mean corpuscular volume (MCV) of infants</measure>
    <time_frame>between Day 1 and Day 27 of life, at infantile age of 16 weeks and of 12 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>infantile genotype of methylenetetrahydrofolate-reductase</measure>
    <time_frame>at infantile age 4 weeks</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>intake of folic acid in breast feeding mothers</measure>
    <time_frame>at the infantile age of 8 weeks</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>intake of MTHF in breast feeding mothers</measure>
    <time_frame>at the infantile age of 8 weeks</time_frame>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">360</enrollment>
  <condition>Growth and Development</condition>
  <arm_group>
    <arm_group_label>infant formula containing folic acid</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Infant formula including folic acid within the range stipulated by European legislation on infant formula</description>
  </arm_group>
  <arm_group>
    <arm_group_label>infant formula containing MTHF</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Infant formula including MTHF instead of folic acid</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Breast milk</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>non randomized reference group</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>infant formula containing folic acid</intervention_name>
    <arm_group_label>infant formula containing folic acid</arm_group_label>
    <other_name>folic acid</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>infant formula containing MTHF</intervention_name>
    <arm_group_label>infant formula containing MTHF</arm_group_label>
    <other_name>L-5-Methyltetrahydrofolate</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Written informed consent (by parents, caregiver)

          -  Healthy male or female infants &lt;28 days of life

          -  Gestational age at delivery ≥37 and ≤42 weeks

          -  Birth weight between 2500 - 4500g

          -  Parents / Caregivers are able to speak Serbian language

        Exclusion Criteria:

          -  Serious acquired or congenital diseases that is expected to interfere with normal
             feeding or growth

          -  Feeding of more than 10% of energy (1 bottle/day) from sources other than the formula
             (or breast milk in the reference group) at inclusion

          -  Participation in another clinical study

          -  Mothers with diabetes mellitus (including gestational diabetes)

          -  Reason to presume that the parents are unable to meet the study plan requirements

          -  Diseases of the mother which have an effect on the child's gastro-intestinal
             tract/ability to be fed

          -  Major abnormalities in hematological parameters

          -  Major abnormalities in hepatic, renal or metabolic functions

          -  Use of medication and vitamin supplements except vitamin K or D supplementation or
             vaccination

          -  Mother follows a vegan diet
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>27 Days</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Berthold Koletzko, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ludwig-Maximilians - University of Munich</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>KBC Dr Dragiša Mišović-Dedinje</name>
      <address>
        <city>Belgrade</city>
        <zip>11000</zip>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HiPP Clinical Study Center</name>
      <address>
        <city>Belgrade</city>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Serbia</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 30, 2015</study_first_submitted>
  <study_first_submitted_qc>May 5, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 8, 2015</study_first_posted>
  <last_update_submitted>January 19, 2018</last_update_submitted>
  <last_update_submitted_qc>January 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Folic Acid</mesh_term>
    <mesh_term>Vitamin B Complex</mesh_term>
    <mesh_term>Tetrahydrofolates</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

